Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 High-sensitivity C-reactive protein levels do not decrease with the use of statins in all persons with HIV infection.

Literature DB >> 21997492

High-sensitivity C-reactive protein levels do not decrease with the use of statins in all persons with HIV infection.

Carl J Fichtenbaum, Scott E Evans, Judith A Aberg.

Abstract

Entities: Chemical Disease Gene Species

Mesh：

Substances：

Year: 2011 PMID： 21997492 PMCID： PMC3432279 DOI： 10.1097/QAD.0b013e32834b9680

Source DB: PubMed Journal: AIDS ISSN： 0269-9370 Impact factor: 4.177

× No keyword cloud information.

2 in total

1. High-sensitivity C-reactive protein levels fall during statin therapy in HIV-infected patients receiving ritonavir-boosted protease inhibitors.

Authors: Elisabeth Aslangul; Soraya Fellahi; Lambert K Assoumou; Jean-Philippe Bastard; Jacqueline Capeau; Dominique Costagliola
Journal: AIDS Date: 2011-05-15 Impact factor: 4.177

2. Treatment with pravastatin and fenofibrate improves atherogenic lipid profiles but not inflammatory markers in ACTG 5087.

Authors: Carl J Fichtenbaum; Tzu-Min Yeh; Scott R Evans; Judith A Aberg
Journal: J Clin Lipidol Date: 2010 Jul-Aug Impact factor: 4.766

2 in total

4 in total

1. Safety and Efficacy of Atorvastatin in Human Immunodeficiency Virus-infected Children, Adolescents and Young Adults With Hyperlipidemia.

Authors: Ann J Melvin; Grace Montepiedra; Lisa Aaron; William A Meyer; Hans M Spiegel; William Borkowsky; Mark J Abzug; Brookie M Best; Marilyn J Crain; Peggy R Borum; Bobbie Graham; Patricia Anthony; Katherine Shin; George K Siberry
Journal: Pediatr Infect Dis J Date: 2017-01 Impact factor: 2.129

High-sensitivity C-reactive protein levels do not decrease with the use of statins in all persons with HIV infection.

1. High-sensitivity C-reactive protein levels fall during statin therapy in HIV-infected patients receiving ritonavir-boosted protease inhibitors.

2. Treatment with pravastatin and fenofibrate improves atherogenic lipid profiles but not inflammatory markers in ACTG 5087.

1. Safety and Efficacy of Atorvastatin in Human Immunodeficiency Virus-infected Children, Adolescents and Young Adults With Hyperlipidemia.

Review 2. Benefits and Risks of Statin Therapy in the HIV-Infected Population.

Review 3. The role of statins in the setting of HIV infection.

Review 4. Statins to improve cardiovascular outcomes in treated HIV infection.